Carga anticolinérgica y su relación con la mortalidad al alta en pacientes mayores hospitalizados
Loading...
Download
Official URL
Full text at PDC
Publication date
2021
Defense date
09/09/2021
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citation
Abstract
Los pacientes mayores presentan mayor riesgo de sufrir RAM provocadas poranticolinérgicos1,2. Se ha descrito que las RAM pueden legar a afectar al 25% de los adultos mayores y que esta prevalencia es aún mayor en mayores hospitalizados, y puede llegar a afectar al 50% de los pacientes3,4.Los fármacos con actividad anticolinérgica pertenecen a subgrupos terapéuticos muy diversos y no se limitan a los fármacos del subgrupo N04A - Agentes anticolinérgicos, sino que incluyen fármacos de otros como grupos como antipsicóticos, antidepresivos o antihistamínicos y son ampliamente utilizados en el tratamiento de la enfermedad de Parkinson, depresión, enfermedades cardiovasculares, incontinencia urinaria, enfermedad pulmonar crónica, asma, rinitis alérgica5,6.Las RAM provocadas por anticolinérgicos pueden ser leves, moderadas o graves,y causar efectos centrales y/o periféricos. Desde el punto de vista asistencial, esto se traduce en que la exposición a anticolinérgicos por parte de pacientes mayores se ha descrito como un factor de riesgo de visitas a urgencias7, de hospitalización7,8,hospitalización asociada a caídas9, y hospitalización asociada a confusión y demencia20,así como un incremento del riesgo de reingreso...
Elderly patients are at increased risk for ADR promoted by anticholinergics 1,2 Anticholinegic ADRs may affect 25% of older adults and that this prevalence is even higher in older hospitalized patients, affecting up to 50% of patients 3,4. Drugs with anticholinergic activity are classified into diverse therapeutic subgroups and are not limited to N04A - Anticholinergic Agents, but include drugs from other subgroups such as antipsychotics, antidepressants or antihistamines and are widely used in the treatment of Parkinson's disease, depression, cardiovascular disease, urinary incontinence, chronic lung disease, asthma, allergic rhinitis 5,6.Mild, moderate or severe, central and peripheral anticholinergic effects have been described. Anticholinergic drug exposure has been described as a risk factor for emergency department visits7, hospitalization7,8, falls 9, confusion and dementia related and readmission risk in the elderly...
Elderly patients are at increased risk for ADR promoted by anticholinergics 1,2 Anticholinegic ADRs may affect 25% of older adults and that this prevalence is even higher in older hospitalized patients, affecting up to 50% of patients 3,4. Drugs with anticholinergic activity are classified into diverse therapeutic subgroups and are not limited to N04A - Anticholinergic Agents, but include drugs from other subgroups such as antipsychotics, antidepressants or antihistamines and are widely used in the treatment of Parkinson's disease, depression, cardiovascular disease, urinary incontinence, chronic lung disease, asthma, allergic rhinitis 5,6.Mild, moderate or severe, central and peripheral anticholinergic effects have been described. Anticholinergic drug exposure has been described as a risk factor for emergency department visits7, hospitalization7,8, falls 9, confusion and dementia related and readmission risk in the elderly...
Description
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Farmacia, Departamento de Farmacología, Farmacognosia y Botánica, leída el 09-09-2021